CTi Biopharma Corp (CTIC.OQ)
15 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|52||2017||Chairman of the Board|
|51||2017||President, Chief Executive Officer, Director|
|62||2017||Chief Financial Officer, Executive Vice President|
|53||2017||Chief Operating Officer|
|72||2017||Interim Chief Medical Officer, Global Head of Translational Medicine, Executive Vice President, Chief Scientific Officer|
- BRIEF-CTI Biopharma Corp Says Co Entered Into A Loan And Security Agreement
- BRIEF-CTI BIOPHARMA FILES FOR MIXED SHELF OF UP TO $200 MLN
- BRIEF-CTI Biopharma reports third quarter 2017 financial results
- BRIEF-CTI Biopharma appoints Laurent Fischer as new board chairman
- BRIEF-CTI Biopharma says completed enrollment in phase 3 PIX306 trial of Pixuvri